ReviewDrug design, development and therapy2025
Advances in the Clinical Application of MAC: A Review of Drug Selection, Combination Therapy, and Administration Methods.
Review in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monitored anesthesia care (MAC) is a widely used anesthetic technique designed to provide titratable sedation and effective analgesia during a variety of medical procedures, ensuring patient comfort and safety. MAC is not only applied in surgical interventions but is also extensively used in diagnostic examinations such as sedation gastrointestinal endoscopy and pediatric magnetic resonance imaging (MRI) scans. With ongoing advances in medical technology, the selection of drugs, optimization of combination strategies, and refinement of administration methods for MAC continue to evolve. This narrative review, based on a structured literature search, summarizes recent developments in MAC drug selection, combination therapy, and administration methods. We highlight the quality and limitations of the current evidence, provide scenario-based practical recommendations, and outline emerging agents and delivery technologies, alongside unresolved questions that warrant further investigation.Overall, the existing evidence indicates that refined drug combinations (eg, propofol or dexmedetomidine in combination with opioids) tailored to specific procedural contexts and individual patient needs, alongside target-controlled infusion technology, are significantly enhancing the safety, comfort, and efficiency of MAC. However, the optimal drug combinations and standardized administration pathways still require further high-quality research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.